13F-HR filed by DEERFIELD MANAGEMENT COMPANY, L.P.
DEERFIELD MANAGEMENT COMPANY, L.P. filed this 13F-HR for the quarter ended 2019-12-31, filed 2020-02-14, with 76 holding rows worth $3,134,215,000.
- Accession
- 0000950159-20-000051
- Filer
- CIK 1009258
- Filed
- 2020-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2019
A holdings report, 76 entries on the cover page, a total value of $3,134,215,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $3,134,215,000 with VALUE read as thousands by filing date, 13F file number 028-05366. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerFlynn Management LLC028-11827
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| HORIZON PHARMA INVT LTD | 44052TAB7 | NOTE 2.500% 3/1 | 144,832,000 | $191,529,000 | thousands by filing date | principal |
| ADAPTHEALTH CORP | 00653Q102 | COMMON STOCK | 17,199,888 | $188,855,000 | thousands by filing date | |
| HORIZON THERAPEUTICS PLC | G46188101 | SHS | 4,742,311 | $171,672,000 | thousands by filing date | |
| MYLAN NV | N59465109 | SHS EURO | 8,151,754 | $163,850,000 | thousands by filing date | |
| NEVRO CORP | 64157FAA1 | BOND | 115,776,000 | $154,250,000 | thousands by filing date | principal |
| ORCHARD THERAPEUTICS PLC | 68570P101 | ADR | 8,862,247 | $121,856,000 | thousands by filing date | |
| TRANSPORTATION & LOGISTI | 438083107 | COM | 5,245,638 | $108,585,000 | thousands by filing date | |
| RHYTHM PHARMACEUTICALS INC | 76243J105 | COM | 4,289,291 | $98,482,000 | thousands by filing date | |
| MIRUM PHARMACEUTICALS INC | 604749101 | COM | 3,448,912 | $84,567,000 | thousands by filing date | |
| TANDEM DIABETES CARE INC | 875372203 | COM NEW | 1,361,345 | $81,150,000 | thousands by filing date | |
| ACCELERON PHARMA INC | 00434H108 | COM | 1,369,625 | $72,618,000 | thousands by filing date | |
| RA PHARMACEUTICALS INC | 74933V108 | COM | 1,519,718 | $71,320,000 | thousands by filing date | |
| CENTENE CORP DEL COM | 15135B101 | Stock | 1,108,400 | $69,685,000 | thousands by filing date | |
| INTERSECT ENT INC | 46071F103 | COM | 2,797,033 | $69,646,000 | thousands by filing date | |
| INTERCEPT PHARMACEUTICALS IN | 45845PAA6 | NOTE 3.250% 7/0 | 57,791,000 | $58,256,000 | thousands by filing date | principal |
| MYOKARDIA INC | 62857M105 | COM | 789,000 | $57,506,000 | thousands by filing date | |
| ARDELYX INC | 039697107 | COM | 7,004,253 | $52,567,000 | thousands by filing date | |
| BROOKDALE SR LIVING INC | 112463104 | COM | 7,223,419 | $52,514,000 | thousands by filing date | |
| SILK ROAD MEDICAL INC | 82710M100 | COMMON STOCK | 1,279,480 | $51,665,000 | thousands by filing date | |
| DBV TECHNOLOGIES S A | 23306J101 | ADR | 4,756,000 | $50,889,000 | thousands by filing date | |
| DEXCOM INC | 252131AH0 | NOTE 0.750%12/0 | 34,000,000 | $50,441,000 | thousands by filing date | |
| ROCKET PHARMACEUTICALS INC | 77313F106 | COM | 2,164,471 | $49,263,000 | thousands by filing date | |
| VERICEL CORP | 92346J108 | COM | 2,747,563 | $47,808,000 | thousands by filing date | |
| BLUEPRINT MEDICINES CORP | 09627Y109 | COM | 564,914 | $45,255,000 | thousands by filing date | |
| ARVINAS INC | 04335A105 | COM | 1,088,234 | $44,716,000 | thousands by filing date | |
| CLOVIS ONCOLOGY INC | 189464AB6 | NOTE 2.500% 9/1 | 49,064,000 | $42,905,000 | thousands by filing date | principal |
| AERIE PHARMACEUTICALS INC | 00771V108 | COM | 1,772,255 | $42,835,000 | thousands by filing date | |
| FATE THERAPEUTICS INC | 31189P102 | COM | 2,002,605 | $39,191,000 | thousands by filing date | |
| SIENTRA INC | 82621J105 | COM | 4,227,680 | $37,795,000 | thousands by filing date | |
| IMMUNOMEDICS INC | 452907108 | COM | 1,722,618 | $36,451,000 | thousands by filing date | |
| ALECTOR INC | 014442107 | COMMON STOCK | 2,076,812 | $35,783,000 | thousands by filing date | |
| EDITAS MEDICINE INC | 28106W103 | COM | 1,158,841 | $34,313,000 | thousands by filing date | |
| SPRINGWORKS THERAPEUTICS INC | 85205L107 | COM | 788,243 | $30,339,000 | thousands by filing date | |
| HUMANA INC COM | 444859102 | Stock | 82,000 | $30,055,000 | thousands by filing date | |
| AUDENTES THERAPEUTICS INC. | 05070R104 | Common Stock | 493,901 | $29,555,000 | thousands by filing date | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 184,000 | $29,536,000 | thousands by filing date | |
| PTC THERAPEUTICS INC | 69366JAB7 | NOTE | 24,877,000 | $28,400,000 | thousands by filing date | principal |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 210,000 | $27,098,000 | thousands by filing date | |
| CONSTELLATION PHARMACEUTICALS INC. | 210373106 | Common Stock | 550,000 | $25,911,000 | thousands by filing date | |
| FREQUENCY THERAPEUTICS INC | 35803L108 | COM | 1,418,665 | $24,869,000 | thousands by filing date | |
| TECTONIC THERAPEUTIC INC COM | 05455M100 | Stock | 1,164,970 | $23,451,000 | thousands by filing date | |
| AXONICS INC | 05465P101 | COM | 837,945 | $23,219,000 | thousands by filing date | |
| TURNING PT THERAPEUTICS | 90041T108 | COM | 366,000 | $22,798,000 | thousands by filing date | |
| CABALETTA BIO INC | 12674W109 | COMMON STOCK | 1,628,504 | $22,750,000 | thousands by filing date | |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 174,000 | $22,422,000 | thousands by filing date | |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 6,375,143 | $21,994,000 | thousands by filing date | |
| REATA PHARMACEUTICALS INC | 75615P103 | CL A | 100,000 | $20,443,000 | thousands by filing date | |
| MOLINA HEALTHCARE INC | 60855R100 | COM | 148,433 | $20,141,000 | thousands by filing date | |
| GLOBAL BLOOD THERAPEUTICS USD | 37890U108 | COM | 251,000 | $19,952,000 | thousands by filing date | |
| EHEALTH INC | 28238P109 | COM | 204,000 | $19,600,000 | thousands by filing date | |
| ADDUS HOMECARE CORP | 006739106 | COM | 197,915 | $19,241,000 | thousands by filing date | |
| DECIPHERA PHARMACEUTICALS IN | 24344T101 | COM | 308,000 | $19,170,000 | thousands by filing date | |
| SELECT MED HLDGS CORP | 81619Q105 | COM | 793,200 | $18,513,000 | thousands by filing date | |
| XERIS PHARMACEUTICALS INC | 98422L107 | COM | 2,583,291 | $18,212,000 | thousands by filing date | |
| FORTY SEVEN INC | 34983P104 | COM | 447,000 | $17,598,000 | thousands by filing date | |
| REVANCE THERAPEUTICS INC | 761330109 | COM | 900,000 | $14,607,000 | thousands by filing date | |
| KODIAK SCIENCES INC | 50015M109 | COM | 200,000 | $14,390,000 | thousands by filing date | |
| Mallinckrodt Plc | G5785G107 | SHS | 4,026,750 | $14,053,000 | thousands by filing date | |
| ORTHOPEDIATRICS CORP | 68752L100 | COMMON STOCK | 225,000 | $10,573,000 | thousands by filing date | |
| ATRICURE INC | 04963C209 | COM | 292,777 | $9,518,000 | thousands by filing date | |
| SYROS PHARMACEUTICALS INC | 87184Q107 | COM | 1,268,946 | $8,768,000 | thousands by filing date | |
| IVERIC BIO INC | 46583P102 | COM | 1,000,000 | $8,580,000 | thousands by filing date | |
| THERAPEUTICSMD INC | 88338N107 | COM | 2,250,000 | $5,445,000 | thousands by filing date | |
| NEURONETICS INC | 64131A105 | COM | 1,075,000 | $4,827,000 | thousands by filing date | |
| X4 Pharmaceuticals, Inc. | 98420X103 | COM | 449,437 | $4,809,000 | thousands by filing date | |
| ICPT 2 05 15 26 2 000000 | 45845PAB4 | CONV BD US | 3,500,000 | $4,632,000 | thousands by filing date | |
| ITAMAR MED LTD SPONSORED ADS | 465437101 | ADR | 314,136 | $4,043,000 | thousands by filing date | |
| PUMA BIOTECHNOLOGY INC | 74587V107 | COMMON STOCK | 396,472 | $3,469,000 | thousands by filing date | |
| SHOCKWAVE MED INC | 82489T104 | COM | 70,000 | $3,074,000 | thousands by filing date | |
| INOGEN INC | 45780L104 | COM | 37,016 | $2,529,000 | thousands by filing date | |
| AERIE PHARMACEUTICALS INC | 00771V108 | COM | 103,800 | $2,509,000 | thousands by filing date | put |
| Adverum Biotechnologies, Inc. | 00773U108 | Common Stock | 211,343 | $2,435,000 | thousands by filing date | |
| ALPINE IMMUNE SCIENCES INC | 02083G100 | COM | 248,992 | $956,000 | thousands by filing date | |
| PROTEON THERAPEUTICS INC | 74371L109 | COM | 2,029,000 | $832,000 | thousands by filing date | |
| NEOS THERAPEUTICS INC | 64052L106 | COM | 320,993 | $485,000 | thousands by filing date | |
| KEMPHARM INC COM NEW | 488445107 | Stock | 517,692 | $196,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000950159-20-000051 | this filing | 2020-02-14 | acceptance time not in the bulk data set |